Uptrend Under Pressure 93
Institutional selling is building — 7 distribution days in the last 25 sessions. Severe risk · 93/100 · 7 distribution days (SPY) Sep 11 Full briefing →
View
Simple research view

BDX · Becton, Dickinson and Company

$176.42 -1.88% Sep 10 close
Detected setup watchlist_candidate · Setup Score 0/100

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Ask about BDX

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

$BDX

Becton, Dickinson and Company

Becton, Dickinson and Company is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $48B.

Health Technology Medical Specialties stock Stage 3 · Topping Base 1
$176.42 latest close
Verdict · setup score 0/100 · data Sep 10 close · 1 session old

Stand aside — setup invalidated

Setup score 0, but distribution days reach 5 or more — stand aside until the condition resets.

Earnings

Normal technical setup

No sourced report date Event risk is not modelled for this symbol

Deterministic evidence

BDX-1.88%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Same completed session window ending 2026-09-10. BDX was -1.33 points vs XLV. -1.28 points vs SPY.

Session internals Weak

Rule: closed flat-to-down and in the bottom third of the range. Judged on internals, not on the size of the move.

Vs prior close-1.88% From the open-1.41% Range position23% GapNo gap
QQQ confirmationConfirming (-1.06%) SMH confirmationConfirming (-2.44%)
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.

Price $176.42 -1.9% Sep 10 close
52W High $213.08 17.2% below high
Wks Since High 29w 30w today
Base Depth 33.0% 34.2% today
RS Rank 12 percentile of scan
SMA 50 $171.46
Avg Vol 1,758,858
Rel Vol (Sep 10) 0.97×
More stats
52W Low $140.11
Tight Wks 1
Base B1
SMA 200 $171.52
RS Line vs High -23.6%
RS Line Slope -0.5% ▼
Group Rank #25/58
ADR% 2.1%
ATR(14) $4.10 (2.3%)
Vol Pace (live) N/A
U/D Vol 1.36
A/D Days 19A / 15D
A/D Rating A
VDU Bars 0/10 d
Position in 52-week range 50thpercentile of the 52-week range
$140.11low
$213.08high

BDX Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BDX.

Create Free Account

Technical Analysis Report Card

$BDX · $176.42 · as of 2026-09-10 · multi-factor read
41
/ 100
Technicals 41/100
Reference read from price & volume only — the verdict at the top of the page decides the action.

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▬ Sideways / consolidating

Moving Averages

50-day$171.46 ↑
100-day$159.78 ↑
200-day$171.52 ↑
Bearish (50 < 200)

RSI (14)

Reading42.2 · Bearish

Bearish momentum — sellers in control.

MACD (12/26/9)

StateWeakening
Histogram-2.373

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width-3% · 9.5%

Piercing the lower band — capitulation or strong selling.

Volume · Buyer vs Seller

Up/Down vol1.36 · Neutral
Rel volume0.97×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $187.35swing level
R · $192.41swing level
R · $213.0852-week high
Price · $176.42now
S · $153.26swing level
S · $148.23swing level
S · $142.47swing level

Fibonacci · Uptrend swing

23.6%$180.57
38.2%$172.84
50.0%$166.59
61.8%$160.34
78.6%$151.44

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for BDX — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendAbove 200-day MA50/200 bearishRS 18 (laggard)
Want this read in a legend's voice? Ask a Legend about BDX
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 3 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D

Trend-template read: fails 150-day MA > 200-day MA.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $176.42, MA150 $162.40, MA200 $171.52
1.5 Price > 50-day MAPrice $176.42 vs MA50 $171.46
Failing evidence
1.2 150-day MA > 200-day MAMA150 $162.40 vs MA200 $171.52
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $171.46, MA150 $162.40, MA200 $171.52
3/10 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
S: Base tightness (ATR% ≤ 4.5%)ATR% 2.33%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+11.4% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 18
1/8 checks
Avoid
Weinstein D

Stage-analysis read: topping (Stage 3) is not an advancing Stage 2.

Passing evidence
Price above 30-week MA (200-day proxy)Price $176.42 vs MA200 $171.52
Not extended from 52-week high (≤ 30% below)17.2% below 52-week high
Failing evidence
Stage 2 (Advancing phase) confirmedStage 3 (Topping)
Volume expansion above averageVolume ratio 0.97x
2/6 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$176.42
Distance from 52-week high17.2% below high
Failing evidence
Relative strengthRS 18
Volume vs average0.97x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$176.42
Distance from 52-week high17.2% below high
Failing evidence
Relative strengthRS 18
Volume vs average0.97x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$176.42
Distance from 52-week high17.2% below high
Failing evidence
Relative strengthRS 18
Volume vs average0.97x
3/6 checks
Base & Breakout
Breakout follow-through

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
81RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +6 A
A: 18 D: 12 Net: +665 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C 2/7 criteria
Separate score from the Minervini Trend Template (4/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ +11%
Revenue growth ≥20% YoY +8%
Gross margin ≥30% 47%
ROE ≥17% 4%
RS rating ≥80 (leadership) 18
Stage 2 uptrend (Weinstein) Stage 3
Within 25% of 52W high -17.2%

Method Playbook

Trade it like Wyckoff EXACT LEVELS · PRO
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →

Pattern Analysis

0 setup score
RS Score 18
Trend template 4/8
Why This Setup?
watchlist_candidate · schematic

Near-miss 4/8 — needs: sma150 above sma200, sma50 above sma150 200, price above 30pct of 52w low, rs score above 70

The Universal Edge Check · context only

What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.

0/7 universals met
  • A relative-strength leader — not met RS rank 12 — laggard
  • Risk is defined — not met No stop — undefined risk
  • Asymmetric reward — partly met No target set
  • Clear of earnings — partly met Report date unknown
  • In a confirmed uptrend — partly met Stage 3 · Trend template 4/8 — not yet Stage 2
  • Not chasing (in range) — partly met Pivot distance unknown
  • Volume confirms — partly met 1.0× average — light
Why these seven? → The Universal Edge

Minervini Trend Template

4/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $176.42 vs SMA150 $162.40 / SMA200 $171.52
SMA 150 above SMA 200 SMA150 $162.40 vs SMA200 $171.52
SMA 200 trending up Slope +0.08 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $171.46
Price above SMA 50 $176.42 vs SMA50 $171.46
30%+ above 52-week low +25.9% from $140.11
Within 25% of 52-week high -17.2% from $213.08
RS score above 70 RS 18

Fundamentals

52W Range
50%
Mkt Cap SEC
48.1B
EPS QoQ
+11%
Rev YoY
+8%
ROE
4%
Gross Margin
47%
D/E
0.76
EPS TTM
$5.82
P/E TTM
30.3x
Float
272M

Company

Company profile
Becton, Dickinson and Company
BDX · NYSE · Health Technology · Medical Specialties

Scan History

20× streak
Sep 09: 0 (watchlist_candidate)Sep 10: 0 (watchlist_candidate)Sep 11: 0 (watchlist_candidate)0
Sep 11
watchlist_candidate
0
Sep 10
watchlist_candidate
0 0.0%
Sep 09
watchlist_candidate
0 -1.9%

Get the full picture on BDX

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.

Start 7-Day Free Trial